Changes of amino acid serum levels in pediatrics patients with higher-risk acute lymphoblastic leukemia (CCG-1961)

In Vivo

Volumn 18, Issue 2, 2004, Pages 107-112

  Grigoryan, Rita S ^a   Panosyan, Edward H ^a   Seibel, Nita L ^b,d   Gaynon, Paul S ^a,c,d   Avramis, Ioannis A ^a   Avramis, Vassilios I ^a,c,d  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Acute lymphoblastic leukemia; Amino acids; Asparaginase; Deamination

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINASE; ASPARAGINE; GLUTAMINE; HISTIDINE; PROLINE; SERINE; THREONINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEAMINATION; ENZYME ACTIVITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PEDIATRICS; PROTEIN DEPLETION;

EID: 1842841753     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ, Ettinger AG, Ettinger LJ, Franklin J, Gaynon PS, Hilden JM, Lange B, Majlessipour F, Mathew P, Needle M, Neglia J, Reaman G, Holcenberg JS and Stork L: A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 99: 1986-1994, 2002.
2. Holland FJ and Takao Ohnuma: Asparaginase and amino acids in cancer therapeutics. Cancer Treat Rep 65(Suppl 4): 123-130, 1981.
3. Avramis VI, Kwock R, Avramis IA, Cohen LJ and Inderlied C: Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: A model of HIV-1-induced T-cell lymphoma. In Vivo 15: 1-10, 2001.
4. Delbecque-Boussard L, Gottrand F, Ategbo S, Nelken B, Mazingue F, Vic P, Farriaux JP and Turck D: Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study. Am J Clin Nutr 65(1): 95-100, 1997.
5. Tisdale MJ: Wasting in cancer. J Nutr 129(1S Suppl): 243S-246S, 1999.
6. Klein CL and Cammitta BM: Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. Cancer Res 43: 5586 (abstract), 1983.
7. Sukemori S and Sugimura K-I: Extracellular glutamine level reduction enhances 5-fluorouracil cytotoxicity. Cancer Biochem Biophys 16: 53-61, 1998.
8. Franek F, Fismolova I and Eckschlager T: Antiapoptotic and proapoptotic action of various amino acids and analogs in starving MOLT-4 cells. Arch Biochem Biophys 1;398(1): 141-146, 2002.
9. Gong H, Zolzer F, von Recklinghausen G, Havers W and Schweigerer L: Arginine deiminase inhibits proliferation of human leukemia cell more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14: 826-829, 2000.
10. Oettgen HF, Stephenson PA, Schwartz MK, Leeper RD, Tallal L, Tan CC, Clarkson BD, Golbey RB, Krakoff IH, Karnofsky DA, Murphy ML and Burchenal JH: Toxicity of E. Coli L-asparaginase in man. Cancer 25(2): 253-278, 1970.
11. Halonen P, Mattila J, Ruuska T, Salo MK and Makipernaa A: Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings. Med Pediatr Oncol 40(3): 148-154, 2003.
12. Land VJ, Sutow WW, Fernbach DJ, Lane DM and Williams TE: Toxicity of L-asparginase in children with advanced leukemia. Cancer 30(2): 339-347, 1972.
13. Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin J Nachman J, Ettinger L, La M, Steinherz P, Cohen U, Siegel SE and Avramis VI: Asparaginase antibody and asparaginase activity in children with higher risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol, in press.
14. Abshire TC, Pollock BH, Billett AL, Bradley P and Buchanan GR: Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 96: 1709-1715, 2000.
15. Gaynon PS, Harris RE, Stram DO, Atlman AJ, Bostrom BC, Breneman J, Hawks R, Steele D, Trigg ME, Uckun FM, Zipf T, Cohen LJ, Fu C and Avramis VI: Asparagine (Asn) depletion and treatment response in acute lymphoblastic leukemia (ALL) after an early marrow relapse: A Children's Cancer Group trial (CCG-1941). Blood 94: 628a (abstract), 1999.
16. Champe PC and Harvey RA: Nitrogen metabolism, Unit V. In: Biochemistry (Champe PC and Harvey RA, eds). Philadelphia, Lippincot-Raven Publishers, 1994, pp 229-268.
17. Grünert A and Heim F: Adjuvant parenteral nutrition in chemo- and radiotherapeutic measures in hematology. Infusionstherapie Und Klinische Ernahrung 13(3): 122-124. 1986.
18. Weijs PJ, Calder AG, Milne E and Lobley GE: Conversion of [15N] ammonia into urea and amino acids in humans and the effect of nutritional status. Br J Nutr 76(4): 491-499, 1996.
19. Hurter T, Reis HE and Borchard F: Disorders of intestinal absorption in patients treated with cytostatic chemotherapy. Z Gastroenterol 27(10): 606-610, 1989.
20. Cooperman JM and Lopez R: The role of histidine in the anemia of folate deficiency. Exp Biol Med (Maywood) 227(11): 998-1000, 2002.